[go: up one dir, main page]

ATA46188A - Antihypercholesterinaemische tetrazol-verbindungen - Google Patents

Antihypercholesterinaemische tetrazol-verbindungen

Info

Publication number
ATA46188A
ATA46188A AT0046188A AT46188A ATA46188A AT A46188 A ATA46188 A AT A46188A AT 0046188 A AT0046188 A AT 0046188A AT 46188 A AT46188 A AT 46188A AT A46188 A ATA46188 A AT A46188A
Authority
AT
Austria
Prior art keywords
antihypercholesterinaemic
tetrazole compounds
tetrazole
compounds
antihypercholesterinaemic tetrazole
Prior art date
Application number
AT0046188A
Other languages
English (en)
Other versions
AT395589B (de
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to AT0037992A priority Critical patent/AT401518B/de
Priority to AT0038292A priority patent/AT401175B/de
Publication of ATA46188A publication Critical patent/ATA46188A/de
Application granted granted Critical
Publication of AT395589B publication Critical patent/AT395589B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0046188A 1987-02-25 1988-02-24 Antihypercholesterinaemische tetrazol-verbindungen AT395589B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT0037992A AT401518B (de) 1987-02-25 1992-02-28 Neue tetrazol-verbindungen und verfahren zu ihrer herstellung
AT0038292A AT401175B (de) 1987-02-25 1992-02-28 Neue tetrazol-verbindungen und verfahren zu ihrer herstellung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1854287A 1987-02-25 1987-02-25
US07/151,513 US4897490A (en) 1987-02-25 1988-02-18 Antihypercholesterolemic tetrazole compounds

Publications (2)

Publication Number Publication Date
ATA46188A true ATA46188A (de) 1992-06-15
AT395589B AT395589B (de) 1993-01-25

Family

ID=26691223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0046188A AT395589B (de) 1987-02-25 1988-02-24 Antihypercholesterinaemische tetrazol-verbindungen

Country Status (31)

Country Link
US (1) US4897490A (de)
JP (1) JP2603324B2 (de)
KR (1) KR960001203B1 (de)
CN (1) CN1026110C (de)
AT (1) AT395589B (de)
AU (1) AU1395088A (de)
BE (1) BE1002116A3 (de)
CA (1) CA1328268C (de)
CH (1) CH676848A5 (de)
CS (1) CS271481B2 (de)
DE (1) DE3805801C2 (de)
DK (1) DK174822B1 (de)
EG (1) EG18341A (de)
ES (2) ES2010246A6 (de)
FI (1) FI96601C (de)
FR (1) FR2612924B1 (de)
GR (1) GR1000472B (de)
HU (3) HU204516B (de)
IE (1) IE61619B1 (de)
IL (1) IL85529A (de)
IT (1) IT1216751B (de)
LU (1) LU87144A1 (de)
MX (1) MX9202847A (de)
MY (1) MY103214A (de)
NL (1) NL8800465A (de)
NO (1) NO169438C (de)
NZ (1) NZ223620A (de)
PT (1) PT86820B (de)
SE (1) SE503618C2 (de)
WO (1) WO1988006584A1 (de)
YU (1) YU36388A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244705B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
US4824959A (en) * 1988-02-18 1989-04-25 Bristol-Myers Company Intermediates for antihypercholesterolemic tetrazole compounds
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US4927944A (en) * 1988-08-25 1990-05-22 Bristol-Myers Company Antihypercholesterolemic nitrile compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5413935A (en) * 1991-04-24 1995-05-09 E. R. Squibb & Sons, Inc. Process for selecting an enantiomer of a hydroxy lactone using pseudomonas lipase
US5134155A (en) * 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
US5986095A (en) * 1992-01-06 1999-11-16 E.R. Squibb & Sons, Inc. Enantioselective preparation of halophenyl alcohols and acylates
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
JPH06329679A (ja) * 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE19714343A1 (de) 1997-04-08 1998-10-15 Bayer Ag Chromatographische Enantiomerentrennung von Lactonen
US6433213B1 (en) * 1997-12-19 2002-08-13 Warner-Lambert Company Process for the synthesis of 1,3-diols
DE10216967A1 (de) * 2002-04-16 2003-11-13 Bayer Ag Verfahren zur Herstellung spezieller aromatischer Aldehyde
EP2178846A1 (de) * 2007-07-12 2010-04-28 Teva Pharmaceutical Industries Ltd. Rosuvastatinzwischenprodukte und ihre herstellung
KR101681041B1 (ko) 2015-07-15 2016-12-22 경북대학교병원 ERRγ 비활성화 리간드로서의 신규한 방향족 고리 화합물 유도체

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
EP0068038B1 (de) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4R.6S)-(E)-6-(2-(4'-Fluor-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-on, Verfahren zu seiner Herstellung und eine diese Verbindung enthaltende pharmazeutische Zusammensetzung
EP0096025A1 (de) * 1981-12-10 1983-12-21 BAYER, Willy Verbrennungsmotor
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
WO1984002131A1 (fr) * 1982-11-22 1984-06-07 Sandoz Ag Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques
IE840153L (en) * 1983-01-24 1984-07-24 Sandoz Ltd Mevalonolactone analogues and related hydroxy acids for¹control of blood cholesterol levels.
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
ATE62906T1 (de) * 1984-06-22 1991-05-15 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds

Also Published As

Publication number Publication date
MX9202847A (es) 1992-06-30
FR2612924B1 (fr) 1991-01-11
SE8800638L (sv) 1988-09-21
KR880009947A (ko) 1988-10-06
CS271481B2 (en) 1990-10-12
NO169438B (no) 1992-03-16
YU36388A (en) 1989-10-31
IL85529A (en) 1993-01-31
IT8819525A0 (it) 1988-02-24
IE61619B1 (en) 1994-11-16
AT395589B (de) 1993-01-25
GR1000472B (el) 1992-07-30
HU896737D0 (en) 1990-02-28
SE503618C2 (sv) 1996-07-15
HU204516B (en) 1992-01-28
FI96601B (fi) 1996-04-15
HU203329B (en) 1991-07-29
BE1002116A3 (fr) 1990-07-10
CA1328268C (en) 1994-04-05
HU204038B (en) 1991-11-28
CN1026110C (zh) 1994-10-05
WO1988006584A1 (en) 1988-09-07
MY103214A (en) 1993-05-29
NZ223620A (en) 1991-07-26
FR2612924A1 (fr) 1988-09-30
SE8800638D0 (sv) 1988-02-24
NO169438C (no) 1992-06-24
NO880809D0 (no) 1988-02-24
JP2603324B2 (ja) 1997-04-23
ES2026746A6 (es) 1992-05-01
CH676848A5 (de) 1991-03-15
KR960001203B1 (ko) 1996-01-24
GR880100101A (en) 1988-12-16
HUT47259A (en) 1989-02-28
PT86820B (pt) 1995-03-01
DK97288D0 (da) 1988-02-24
IL85529A0 (en) 1988-08-31
FI880869A0 (fi) 1988-02-24
JPH01502269A (ja) 1989-08-10
NO880809L (no) 1988-08-26
AU1395088A (en) 1988-09-26
DE3805801A1 (de) 1988-09-08
LU87144A1 (fr) 1988-09-20
CN88100911A (zh) 1988-09-28
CS118088A2 (en) 1989-08-14
IT1216751B (it) 1990-03-08
FI96601C (fi) 1996-07-25
PT86820A (pt) 1989-02-28
US4897490A (en) 1990-01-30
FI880869A7 (fi) 1988-08-26
NL8800465A (nl) 1988-09-16
DE3805801C2 (de) 2001-03-01
HU900669D0 (en) 1990-06-28
ES2010246A6 (es) 1989-11-01
EG18341A (en) 1993-08-30
IE880501L (en) 1988-08-25
DK174822B1 (da) 2003-12-08
DK97288A (da) 1988-08-26

Similar Documents

Publication Publication Date Title
DK85993A (da) 2-anilino-4-formyl-pyrimidinforbindelser
BA98296A (bs) Piperazinil-heterociklicna jedinjenja
FI893632A7 (fi) Yhdisteitä
PT86651A (pt) Chemical compounds
BR8807217A (pt) Compostos heterocilicos
DK321688A (da) Heterocykliske forbindelser
FI895936A7 (fi) Yhdisteitä
DK90788D0 (da) Kemiske forbindelser
ATA46188A (de) Antihypercholesterinaemische tetrazol-verbindungen
FI890438A7 (fi) Yhdisteet
NO168305C (no) Heterocykliske forbindelser
DK64788A (da) Heterocycliske forbindelser
PT86766A (pt) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
AT387258B (de) Fallbremse
IT1221792B (it) Composti metossimetilici
FI893924A7 (fi) Yhdisteitä
NO178432C (no) Tetrazolmellomprodukt
ATE93512T1 (de) Oximino-aether-verbindungen.
KR890700561A (ko) 살충성 시클로프로필-치환된 디 화합물
DE3878192D1 (de) N-phenyltetrahydrophthalimidverbindungen.
DK429588A (da) Heterocykliske forbindelser
FI103793B1 (fi) Tetratsolijohdannaisia
KR890002990U (ko) 관계수
SE8705089D0 (sv) New compounds
SE8702228D0 (sv) New compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time